Consolidated Statement Of Changes In Equity

OncoTherapy Science, Inc. - Filing #7253509

Concept 2024-04-01 to
2025-03-31
As at
2025-03-31
As at
2025-03-31
2024-04-01 to
2025-03-31
As at
2025-03-31
2024-04-01 to
2025-03-31
2024-04-01 to
2025-03-31
As at
2025-03-31
2024-04-01 to
2025-03-31
2024-04-01 to
2025-03-31
2024-04-01 to
2025-03-31
As at
2025-03-31
2024-04-01 to
2025-03-31
As at
2025-03-31
As at
2025-03-31
As at
2025-03-31
2024-04-01 to
2025-03-31
As at
2025-03-31
2024-04-01 to
2025-03-31
As at
2025-03-31
2024-04-01 to
2025-03-31
As at
2025-03-31
2024-04-01 to
2025-03-31
As at
2025-03-31
As at
2025-03-31
As at
2025-03-31
As at
2025-03-31
2024-04-01 to
2025-03-31
2024-04-01 to
2025-03-31
2024-04-01 to
2025-03-31
2024-04-01 to
2025-03-31
As at
2025-03-31
2024-04-01 to
2025-03-31
As at
2025-03-31
As at
2024-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
As at
2024-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
As at
2024-03-31
As at
2024-03-31
As at
2024-03-31
As at
2024-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
As at
2024-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
As at
2024-03-31
As at
2024-03-31
As at
2024-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
As at
2024-03-31
As at
2024-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
As at
2024-03-31
As at
2024-03-31
As at
2024-03-31
As at
2024-03-31
2023-04-01 to
2024-03-31
As at
2024-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
As at
2023-03-31
As at
2023-03-31
As at
2023-03-31
As at
2023-03-31
As at
2023-03-31
As at
2023-03-31
As at
2023-03-31
As at
2023-03-31
As at
2023-03-31
As at
2023-03-31
As at
2023-03-31
As at
2023-03-31
As at
2023-03-31
As at
2023-03-31
As at
2023-03-31
As at
2023-03-31
As at
2023-03-31
Consolidated statement of changes in equity
Statement of changes in equity
Net assets
70,950,000 JPY
-4,000 JPY
27,388,343,000 JPY
15,201,782,000 JPY
658,244,000 JPY
50,000,000 JPY
658,161,000 JPY
-4,000 JPY
50,000,000 JPY
27,516,414,000 JPY
12,186,560,000 JPY
-26,780,094,000 JPY
-26,908,248,000 JPY
-26,780,094,000 JPY
729,111,000 JPY
729,194,000 JPY
70,950,000 JPY
74,500,000 JPY
50,000,000 JPY
279,166,000 JPY
14,604,641,000 JPY
-2,000 JPY
-25,964,891,000 JPY
26,322,132,000 JPY
-26,092,962,000 JPY
-25,964,891,000 JPY
26,194,061,000 JPY
-2,000 JPY
11,589,419,000 JPY
50,000,000 JPY
353,666,000 JPY
279,166,000 JPY
74,500,000 JPY
353,666,000 JPY
77,260,000 JPY
-24,957,108,000 JPY
789,114,000 JPY
789,114,000 JPY
-24,957,108,000 JPY
10,455,605,000 JPY
777,908,000 JPY
574,812,000 JPY
24,793,617,000 JPY
24,665,547,000 JPY
JPY
JPY
855,169,000 JPY
14,209,941,000 JPY
497,552,000 JPY
-24,804,823,000 JPY
77,260,000 JPY
Changes during period
Issuance of new shares
597,141,000 JPY
597,141,000 JPY
597,141,000 JPY
1,194,282,000 JPY
1,194,282,000 JPY
1,194,282,000 JPY
597,141,000 JPY
1,194,282,000 JPY
597,141,000 JPY
789,400,000 JPY
394,700,000 JPY
394,700,000 JPY
394,700,000 JPY
789,400,000 JPY
789,400,000 JPY
394,700,000 JPY
789,400,000 JPY
394,700,000 JPY
Profit (loss) attributable to owners of parent
-815,285,000 JPY
-815,285,000 JPY
-815,285,000 JPY
-1,288,138,000 JPY
-1,288,138,000 JPY
-1,288,138,000 JPY
Net changes in items other than shareholders' equity
-3,550,000 JPY
-3,550,000 JPY
-3,550,000 JPY
-3,550,000 JPY
-2,760,000 JPY
-2,760,000 JPY
-2,760,000 JPY
-2,760,000 JPY
Total changes during period
-3,550,000 JPY
597,141,000 JPY
1,194,282,000 JPY
-1,000 JPY
-1,000 JPY
597,141,000 JPY
JPY
-815,202,000 JPY
379,077,000 JPY
375,527,000 JPY
378,994,000 JPY
JPY
375,444,000 JPY
-815,285,000 JPY
-815,202,000 JPY
-3,550,000 JPY
1,194,282,000 JPY
-2,760,000 JPY
-1,007,782,000 JPY
-498,741,000 JPY
-739,114,000 JPY
-739,114,000 JPY
394,700,000 JPY
-218,385,000 JPY
-221,145,000 JPY
1,133,814,000 JPY
-2,000 JPY
-1,007,782,000 JPY
-1,288,138,000 JPY
1,528,514,000 JPY
-501,502,000 JPY
-2,000 JPY
1,528,514,000 JPY
-2,760,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.